Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Sells $62,387.60 in Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 6,445 shares of the firm’s stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $9.68, for a total transaction of $62,387.60. Following the sale, the chief executive officer now owns 214,563 shares of the company’s stock, valued at $2,076,969.84. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Lisa Utzschneider also recently made the following trade(s):

• On Monday, May 6th, Lisa Utzschneider sold 8,044 shares of Integral Ad Science stock. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68.

Integral Ad Science Stock Performance

IAS opened at $9.94 on Friday. The company has a current ratio of 4.32, a quick ratio of 4.32 and a debt-to-equity ratio of 0.13. The company has a market cap of $1.60 billion, a price-to-earnings ratio of 994.99, a PEG ratio of 1.69 and a beta of 1.53. The company’s 50 day moving average is $9.54 and its 200 day moving average is $11.44. Integral Ad Science Holding Corp. has a 12-month low of $7.98 and a 12-month high of $20.88.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). Integral Ad Science had a net margin of 0.59% and a return on equity of 0.32%. The business had revenue of $114.50 million for the quarter, compared to the consensus estimate of $112.12 million. During the same quarter in the previous year, the firm earned $0.02 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, equities research analysts predict that Integral Ad Science Holding Corp. will post 0.22 EPS for the current year.

Hedge Funds Weigh In On Integral Ad Science

Several large investors have recently added to or reduced their stakes in the company. M&T Bank Corp lifted its holdings in Integral Ad Science by 5.6% during the fourth quarter. M&T Bank Corp now owns 14,430 shares of the company’s stock valued at $207,000 after purchasing an additional 770 shares in the last quarter. Ameritas Investment Partners Inc. lifted its holdings in Integral Ad Science by 40.1% during the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares in the last quarter. American Trust lifted its holdings in Integral Ad Science by 18.0% during the first quarter. American Trust now owns 13,742 shares of the company’s stock valued at $137,000 after purchasing an additional 2,096 shares in the last quarter. Truist Financial Corp lifted its holdings in shares of Integral Ad Science by 25.7% in the fourth quarter. Truist Financial Corp now owns 22,872 shares of the company’s stock worth $329,000 after buying an additional 4,676 shares in the last quarter. Finally, Richelieu Gestion SA lifted its holdings in shares of Integral Ad Science by 35.0% in the first quarter. Richelieu Gestion SA now owns 19,501 shares of the company’s stock worth $194,000 after buying an additional 5,055 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Craig Hallum reduced their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, May 10th. Loop Capital began coverage on shares of Integral Ad Science in a research note on Tuesday, April 30th. They set a “buy” rating and a $15.00 price objective for the company. Morgan Stanley reiterated an “equal weight” rating and issued a $12.00 price target (down from $18.00) on shares of Integral Ad Science in a research note on Tuesday, April 16th. Raymond James reduced their price target on shares of Integral Ad Science from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Friday, May 10th. Finally, Barclays reduced their price target on shares of Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, April 15th. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $16.77.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.